论文信息 - Phase I–II study of vorinostat plus paclitaxel and bevacizumab in metastatic breast cancer: evidence for vorinostat-induced tubulin acetylation and Hsp90 inhibition in vivo - 字舞流文

Phase I–II study of vorinostat plus paclitaxel and bevacizumab in metastatic breast cancer: evidence for vorinostat-induced tubulin acetylation and Hsp90 inhibition in vivo

B. Ramaswamy | C. Shapiro | M. Goetz | J. Sparano | K. Bhalla | V. Stearns | P. Christos | R. Swaby | G. Somlo | D. Hershman | E. Chuang | T. Luu | I. Espinoza‐Delgado | W. Fiskus | B. Cohen | C. Pellegrino